Kardigan (KARD) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 24 99 sessions, June 18, 2026 to November 6, 2026
- Largest daily move
- +12% close of November 6, 2026
- 1-month change
- +15% closing prices, October 6, 2026 to November 6, 2026
Company Description
Kardigan (NASDAQ: KARD) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.5B.
KARD has gained 15.0% over the past month. The last closing price was $15.52.
This page collects what Stock Titan holds for KARD, including price data, latest news, SEC filings, upcoming events, and short interest trends.
Stock Performance
Kardigan (KARD) closed at $15.52 on November 6, 2026. Over the past month, the price has gained 15.0%.
KARD Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Kardigan has 6 recent news articles, with the latest published 3 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial, management, earnings, IPO, offering. View all KARD news →
SEC Filings
Kardigan has filed 10 recent SEC filings, including 3 Form 8-K, 2 Form SCHEDULE 13G, 1 Form 3, 1 Form 4. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KARD SEC filings →
Financial Highlights
Upcoming Events
Danicamtiv topline data
Ataciguat topline data
Tonlamarsen topline data
Phase 3 update
Week 48 topline results
Kardigan has 5 upcoming scheduled events. The next event, "Danicamtiv topline data", is expected in H1 2027. Investors can track these dates to stay informed about potential catalysts that may affect the KARD stock price.
Short Interest History
Short interest in Kardigan (KARD) currently stands at 5.3 million shares, up 19.3% from the previous reporting period, representing 9.8% of the float. Since June 2026, short interest has increased by 261.0%.
Days to Cover History
Days to cover for Kardigan (KARD) currently stands at 7.6 days, up 102.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since June 2026, the figure has increased by 464.4%. Across the settlements charted above, it has ranged from 1.4 to 9.3 days.
KARD Company Profile & Sector Positioning
Kardigan (KARD) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing KARD often look at related companies in the same sector, including uniQure N.V. (QURE), Nuvation Bio Inc. (NUVB), Damora Therapeutics, Inc. (DMRA), Tyra Biosciences, Inc. (TYRA), and Structure Therapeutics Inc. (GPCR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KARD's relative position within its industry.